Previous Nav
Net Change on 26-05-2023
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
SUN PHARMACEUTICAL INDUSTRIES LTD
CIPLA LTD
DR REDDYs LABORATORIES LTD
LUPIN LTD
ALKEM LABORATORIES LTD
DIVI LABORATORIES LTD
FORTIS HEALTHCARE LTD
AUROBINDO PHARMA LTD
A) REPO
APOLLO HOSPITALS ENTERPRISE LTD
HEALTHCARE GLOBAL ENTERPRISES LTD
FDC LTD
KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD
IPCA LABORATORIES LTD
ZYDUS LIFESCIENCES LTD
GLENMARK PHARMACEUTICALS LTD
INDOCO REMEDIES LTD
GLAND PHARMA LTD
ASTER DM HEALTHCARE LTD
MANKIND PHARMA LTD
AJANTA PHARMA LTD
PROCTER & GAMBLE HEALTH LTD
MEDPLUS HEALTH SERVICES LTD
ABBOTT INDIA LTD
TORRENT PHARMACEUTICALS LTD
SYNGENE INTERNATIONAL LTD
CASH / NET CURRENT ASSET
GLAXOSMITHKLINE PHARMACEUTICALS LTD
SANOFI INDIA LTD
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Cash
Equity
Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹512.42 crore. Tata India Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.
The NAV of Tata India Pharma & Healthcare Fund ended up ₹0.17(1%)yesterday to ₹16.7732.
Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD, and
The Tata India Pharma & Healthcare Fund is managed by Meeta Shetty .
1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051